Compare Duke Energy Corp (DUK) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs Novavax Inc — how do they compare? Duke Energy Corp trades at $116.65 (market cap $91.10B), while Novavax Inc trades at $12.75 (market cap $1.82B). The key difference: Duke Energy Corp is far larger — about 50.1× Novavax Inc's market cap, and Duke Energy Corp pays a 3.71% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Duke Energy Corp for 74 Days and Novavax Inc for 59 Days on average.
| DUK | NVAX | |
|---|---|---|
Market Cap | $91.10B | $1.82B |
Volume | 4,199,050 | 6,198,505 |
Sector | Utilities | Health |
52-Week High | $133.46 | $12.75 |
52-Week Low | $113.23 | $6.22 |
Typical Hold Time | 74 Days | 59 Days |
Enterprise Value | $183.61B | $1.39B |
Dividend Yield | 3.71% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $116.84, up 1.16% with a bullish technical signal despite mixed moving averages. The company shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 15.78% net margin, and stable dividend payments. Revenue growth accelerated from $28.8B in 2022 to $32.24B in 2025, with positive cash flow trends emerging in 2026 forecasts.
DUK offers a balanced investment case with 40.6% analyst buy ratings and $134.44 consensus target, representing 15% upside. Key risks include rising Treasury yields pressuring utility stocks and elevated debt levels at 46.17% of assets. The data center expansion opportunity provides growth catalysts amid regulatory stability.
Novavax (NVAX) trades at $11.01, down 1.87% on the day, with a bullish technical signal from moving averages and a strong buy consensus from analysts (73.9% buy ratings). The company reported a net income of $440.3M in 2025, a significant turnaround from prior losses, though 2026 projections show a return to negative margins. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivots toward its Matrix-M adjuvant platform through partnerships.
The outlook is mixed: near-term catalysts include partnership-driven growth and vaccine approvals, but persistent cash burn and projected 2026 losses pose risks. Investor sentiment is buoyed by recent earnings beats and strategic shifts, yet execution on profitability remains critical for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
